CC2D2B Inhibitors
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $150.00 $388.00 | 113 | |
Staurosporine is a potent inhibitor of protein kinases, which can indirectly lead to the inhibition of CC2D2B if CC2D2B's function is modulated by phosphorylation. By inhibiting the kinase activity, staurosporine would prevent the phosphorylation of CC2D2B, potentially reducing its activity if phosphorylation is a requirement for its function. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
LY294002 is a phosphoinositide 3-kinases (PI3K) inhibitor. If CC2D2B operates downstream of PI3K signaling, inhibition of PI3K would result in reduced activation of pathways that may be necessary for CC2D2B activity, thus leading to its functional inhibition. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
Rapamycin is an mTOR inhibitor. If CC2D2B is involved in pathways regulated by mTOR, such as cell growth and proliferation, rapamycin would lead to a decrease in CC2D2B's function by inhibiting these pathways, assuming CC2D2B is a positive regulator within these pathways. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $39.00 $90.00 | 212 | |
PD98059 is a MEK inhibitor, which blocks the MAPK/ERK pathway. If CC2D2B functions downstream of the MAPK/ERK pathway or is regulated by it, then inhibition of MEK would lead to decreased CC2D2B activity by preventing its activation through this pathway. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $88.00 $342.00 | 284 | |
SB203580 is a p38 MAPK inhibitor. It would inhibit the function of CC2D2B if the protein's activity is modulated via the p38 MAPK signaling pathway. By blocking p38 MAPK, SB203580 would indirectly prevent the activation or proper functioning of CC2D2B if it is a component of this signaling cascade. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $63.00 $241.00 | 136 | |
U0126 is another MEK inhibitor, which would lead to the inhibition of CC2D2B activity by blocking MEK1/2, assuming that CC2D2B is regulated by the MEK/ERK pathway. This would result in the downregulation of the ERK pathway, thereby inhibiting the activity of CC2D2B if it is part of this signaling cascade. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 is an inhibitor of c-Jun N-terminal kinase (JNK). If CC2D2B's activity is associated with the JNK signaling pathway, inhibition of JNK by SP600125 would lead to a decrease in CC2D2B activity by preventing its activation within this signaling pathway. | ||||||
WZ4003 | 1214265-58-3 | sc-473979 | 5 mg | $300.00 | ||
WZ4003 is a selective inhibitor of NUAK kinases. If CC2D2B is regulated through NUAK signaling pathways, inhibition by WZ4003 would decrease CC2D2B activity by disrupting the associated signaling that would typically result in CC2D2B activation. | ||||||
BIX 02189 | 1094614-85-3 | sc-364436 sc-364436A | 5 mg 10 mg | $220.00 $378.00 | 5 | |
BIX 02189 is an inhibitor of MEK5, which is part of the ERK5 pathway. If CC2D2B is regulated by ERK5 signaling, inhibition by BIX 02189 would lead to decreased activity of CC2D2B by preventing its activation or the propagation of signals within this pathway. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $182.00 $693.00 | 88 | |
Y-27632 is a Rho-associated protein kinase (ROCK) inhibitor. If CC2D2B functions downstream of ROCK signaling, Y-27632 would inhibit CC2D2B activity by blocking ROCK, which could be necessary for the proper functioning or activation of CC2D2B. | ||||||